8. Explanatory Notes (if any): | *** Consistent with footnote 348 in Release No. IC-33836, to facilitate the
transition to calculating fees on Form 24F-2, the Fund has included in
Item 5 (iii) the amount of excess shares that were registered under the
Fund's registration statement on Form N-2 that remain unsold at the end
of the Fund's prior fiscal year, March 31, 2024, in connection with
the effectiveness of Rule 24f-2 as applied to interval funds. Specifically,
the Fund sold shares with an aggregate value of $27,770,723.00 since inception and
had $491,729,206.00 of shares that were registered under Form N-2 and remained unsold
at the end of the Fund' prior fiscal year, March 31, 2024, in connection
with the effectiveness of Rule 24f-2 as applied to interval funds. *** |